X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BGNE

Closed

Beigene Ltd

226.71
+42.00 (+22.74%)
Last Update: 29 Jan 2025 17:30:00
Yesterday: 184.71
Day's Range: 224.61 - 228.865
Send
When Written:
 
215.53
BeiGene Ltd is a biotechnology company that focuses on developing and commercializing innovative cancer drugs. The company was founded in 2010 in Beijing, China, and has since expanded globally with offices in the United States, Europe, and Asia. BeiGene's product portfolio includes several oncology drugs, including zanubrutinib (Brukinsa), tislelizumab (BGB-A317), and pamiparib (BGB-290). The company is also actively pursuing research and development in other therapeutic areas, such as autoimmune diseases and infectious diseases. BeiGene has partnerships and collaborations with various pharmaceutical companies and academic institutions. The company is listed on the NASDAQ stock exchange under the ticker symbol "BGNE."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X